Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program

Sun Pharma completes acquisition of Concert Pharmaceuticals Source link

Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules Source link

Sun Pharma to announce third quarter results on January 31, 2022 Source link

Sun Pharma launches CEQUA™ (cyclosporine ophthalmic solution 0.09% w/v), the first dry eye treatment with nanomicellar (NCELL™) technology*, in Canada...

Q3 FY22 Financial Press Release Source link

Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the...